Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2003
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2477734A1 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003CA2477265A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/08/2003EP1350541A1 Use of dehydroepiandrosterone and an estradiol derivative for preparing a medicament for treating postmenopausal climacteric disorders
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
10/08/2003EP1349551A2 A method for treating erectile dysfunction
10/08/2003EP1198464B1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES
10/08/2003EP1150683B1 Utilization of dienogest in high doses
10/08/2003EP1140934B1 Benzisoxazoles and phenones as alpha-2-antagonists
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0812319B9 2-arylbenzazole compounds
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447690A Inhibition of cystic fibrosis transmembrane conductance regulator chloride channel
10/08/2003CN1446813A Novel dihydric indole compound, their prepn. process and medicinal compsns. contg.them
10/08/2003CN1446579A Medicine for treating sexually transmission disease
10/08/2003CN1446572A Granule of ÔÇÿJingangtengÔÇÖ for treating inflammatory gynecopathy and its preparation method
10/08/2003CN1446562A Quick dissolving sensitive layer for treating gynecopathy
10/08/2003CN1446555A Medicine for treating insufficiency of the kidney-yang syndrome and its preparing method
10/08/2003CN1446540A Combination of semisolid framework preparation of progesterone
10/08/2003CN1123573C 2-phenyl substituted imidazotrizainones as phosphodiesterase inhibitors
10/08/2003CN1123353C Chinese patent medicine for treating nenoxenia
10/08/2003CN1123352C Cold eliminating pills
10/08/2003CN1123349C Powder for increasing spermic and helping conception
10/07/2003US6630500 Treating angiogenic disorders
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630453 Androgen derivatives and uses thereof
10/07/2003US6630128 Insoluble support
10/07/2003CA2373821C Topical compositions for prostaglandin e1 delivery
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003080642A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080171A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080074A1 Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
10/02/2003WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080047A1 Phosphate prodrugs of fluorooxindoles
10/02/2003WO2003080022A2 Analgesics for nasal administration
10/02/2003WO2003080021A2 Formulation comprising buprenorphine
10/02/2003WO2003079981A2 Bioadhesive drug delivery system
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003051370A8 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003016316A8 Diazacycloalkanes as oxytocin agonists
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003US20030187260 Thienopyrimidines
10/02/2003US20030187047 Vision defects; non-insulin diabetic agents; impotency; dietetics
10/02/2003US20030187004 Central nervous system disorders; Alzheimer's disease
10/02/2003US20030186996 Angiogenesis inhibitors
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186970 Androgen receptor modulator compounds and methods
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186870 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030185900 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar (C12H22O11), and water.
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479718A1 Analgesics for nasal administration
10/02/2003CA2479372A1 Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/02/2003CA2479256A1 Phosphate prodrugs of fluorooxindoles
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478330A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
10/02/2003CA2477651A1 Kinase inhibitors
10/01/2003EP1348706A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
10/01/2003EP1348704A1 Indole derivatives as 5-HT2C antagonists, process for their preparation and pharmaceutical compositions containing them
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348439A1 Compositions for vaginal use
10/01/2003EP1348438A1 Compositions comprising d-chiro-inositol for treating hyperlipidemia
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347979A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
10/01/2003EP1347977A1 Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones
10/01/2003EP1347972A1 Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 557